Latest information on COVID-19

ViRx@STANFORD

Virus Treatment (Rx)

BiosEcuRity & PandEmic PrepAreDness Initiative

“BE READI”

Why Do We Need to
BE READI

COVID 19 - A WAKE UP CALL !!!

~ 10 million ( ~ 0.2% of the current world population) have died from Covid 19

Over $10 trillion have been lost

1918 Flu: 50-100 million (5%-10% of the world population) died (100x more severe than COVID-19)

A future pandemic can be more severe. We are NOT prepared.

Why Do We Need to “BE READI

COVID 19 - A WAKE UP CALL !!!

~ 10 million ( ~ 0.2% of the current world population) have died from Covid 19

Over $10 trillion have been lost

1918 Flu: 50-100 million (5%-10% of the world population) died (100x more severe than COVID-19)

A future pandemic can be more severe. We are NOT prepared.

Our Unique Solution

Medications to treat viruses are key to ending a pandemic, especially when deployed early. Even the fastest vaccine takes one year to deploy and millions can die meanwhile

Expand our collective antiviral toolkit, so as to be better prepared to counter pandemics proactively

Protect our next generation from future pandemics

Vision

vision

Global Impact

From Local to Global

A new world model for Biosecurity and Pandemic Response

Stanford is the ideal place for high risk, high reward, high impact, early stage antiviral drug development for the next pandemic

Stanford will uniquely focus on building out our collective antiviral toolkit - proactively rather than reactively.

Start locally. Then build out to the world

Enable countries to combat their important viral diseases

Excellence Across Team Members. Examples:

Jeffrey Glenn

Jeffrey Glenn

MD/PhD, U.C.S.F

Learn More
Edward Pham

Edward Pham

MD/PhD, Stanford

Learn More
Menashe Elazar

Menashe Elazar

PhD

Learn More
Mark Smith

Mark Smith

PhD in Chemistry

Learn More
Wendy Nguyen

Wendy Nguyen

Strategic Advisor

Learn More
Sally Shekou

Sally Shekou

Strategic Advisor

Learn More
Lee Domanico

Lee Domanico

Strategic Advisor

Learn More

World-class Scientific Advisory Board

Hot Topic

Professor of Medicine and of Microbiology & Immunology Stanford University

Professor of Medicine and of Microbiology & Immunology Stanford University

Jeffrey Glenn, M.D., Ph.D. is a Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology at Stanford University School of Medicine, and the Director of the Center for Hepatitis and Liver Tissue Engineering.

READ MORE
Interferon therapy shows striking results against COVID-19

Interferon therapy shows striking results against COVID-19

From the earliest days of the pandemic, scientists have hoped that interferons, a family of potent proteins that are the body’s own first line of defense against viruses, could become weapons against SARS-CoV-2.

READ MORE
Antiviral Program for Pandemics

Antiviral Program for Pandemics

The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.

READ MORE
Dr. Jeffrey Glenn
Dr. Edward Pham
EdwardPham
Jeffrey Glenn MD/PhD, U.C.S.F Director ViRx@Stanford; Professor of Medicine/Microbiology and Immunology, Stanford University School of Medicine, Director, ViRx@Stanford

Dr. Jeffrey Glenn is a Professor of Medicine, Microbiology & Immunology at Stanford University, and the Director of the Center for Hepatitis and Liver Tissue Engineering. He is the founder of Eiger Biopharmaceuticals who is developing Lambda for hepatitis delta and COVID.

Dr. Glenn is an author on over 100 scientific articles and book chapters, and has been an active consultant for a variety of biotechnology and large pharmaceutical companies. He is the principal investigator on multiple NIH grants, and a member of FDA Antiviral Drugs.

He is an international authority on developing novel antiviral therapeutics.

EdwardPham
Edward Pham MD/PhD, Stanford Deputy Director, Translational Research ViRx@Stanford for Vietnam

Dr. Edward Pham receives his MD and Ph.D in Microbiology & Immunology from Stanford University.

His research focus is on novel antiviral therapies for current and emerging viral infections and the relationship between chronic viral infection and cancer including liver cancer through studying how the innate and adaptive immune system are perturbed in chronic viral infection.

He has been recognized by many prestigious awards such as National Research Service Fellowship from NIH for MD/PhD, Gates Millenium Scholar, Howard Hughes Medical Institute, International Achievement Summit Delegate.

EdwardPham
Mark Smith PhD, University of Manchester Head of Medicinal Chemistry of Stanford

Dr. Mark Smith joined Stanford ChEM-H in May 2013 as the Head of the Medicinal Chemistry Knowledge Center. He graduated with a Ph.D. from the laboratory of Prof. Richard Stoodley at the University of Manchester Institute for Science and Technology (UMIST), where his research focused on the application of Lewis acid catalyzed hetero Diels-Alder reactions to the synthesis of novel disaccharide structures. In 2000, Dr.

Smith joined the research laboratory of Prof. David Crich at the University of Illinois at Chicago. Here his research focused on the generation of new reagents for the synthesis of beta-mannosides from thioglycosides. From 2002 to 2013, Dr. Smith worked as a medicinal chemist in Roche’s research facilities both in Palo Alto, CA and then Nutley, NJ, where he specialized in antiviral research.

EdwardPham
Wendy Nguyen Strategic Advisor 10+ years of experience in Healthcare Management M.S from U.C.S.F

Wendy is the CEO of IMI.AI, a company that allow doctors to give medical advice to patients seamlessly. Wendy has a proven executive management track record with almost ten years of experience in the healthcare and business industry. Wendy was previously Co-founder/CEO of Med2lab, a startup focuses on innovating medical training. The system got adopted by Stanford School of Medicine.

Before that, she spent 5 years in the Management Team at Marin General Hospital, working closely with the CEO, Lee Domanico, as her mentor. Wendy also acts as the President and Founder of Apollo Care, a 501(c)3 nonprofit organization that provides free healthcare support to poor children oversea. She’s also an alumni of Y Combinator founder track, one of the top incubators in the world.

Wendy attended Graduate program from the University of California, San Francisco and a Bachelor Degree in Psychology from UMass Amherst.

EdwardPham
Sally Shekou Strategic Advisor 20+ years of experience in real estate, joint Venture, Commercial Finance Board Member of Marin FoundationJD from Berkeley

Ms. Shekou has over 20 years of experience in real estate acquisitions and dispositions, commercial leasing, joint venture formations and commercial finance. She’s a major philanthropist and a Board Member of Marin Foundation and Marin Symphony.

Ms. Shekou is a member of American Bar Association and recognized numerous times as Super Lawyer in Northern California. She graduated with Highest Honors from University of California, Berkeley law and member of Phi Beta Kapa Honor Society.

EdwardPham
Lee Domanico Strategic Advisor Former CEO of Marin 30+ years of experience as a Hospital and Health System CEO M.S from Stanford

Lee Domanico has led hospitals and health systems across the country. He is known for his ability to transform underperforming organizations into those of high achievement. Lee served as the Chief Executive Officer of MarinHealth, in Marin County, CA, where he led the transfer of the hospital from a large system to a successful free-standing publicly accountable hospital. He secured financing and built the operating and governance organization that currently oversees MarinHealth Medical Center (MHMC), starting with only 7 days of cash on hand. Recently the hospital raised $400M in public funding; $65M in philanthropy and $100M in debt to rebuild the hospital. Secured $340M in new funding through strategic alliance with major academic health system. Under his leadership, MHMC has received numerous awards for quality and safety and is ranked in the top 5% nationally for safety and clinical outcomes. Implemented full telehealth/technology program in response to COVID-19 Pandemic.

Prior to MarinHealth, Lee led El Camino Hospital in Mountain View, California. Under his leadership, El Camino Hospital became one of the most profitable district hospitals in the State and developed superlative medical programs. Prior to joining El Camino Hospital, Domanico led the re-emergence of the Allegheny Health System in Philadelphia from bankruptcy to healthy profits, where he received the “Philadelphia Business Leader of the Year” award.

Domanico previously held executive leadership positions as CEO at the Columbus-Cabrini Health System in Chicago, IL, as V.P in Los Angeles, CA, and as Sr. V.P. of Pennsylvania with Tenet Healthcare, and as CEO of Legacy Health System in Portland, Oregon.

Domanico is known for establishing healing, patient-centric hospital environments and for early adoption of cutting-edge medical technologies. He has 30+ years of experience as a Hospital and Health System CEO.

Domanico holds a BS degree (Magna Cum Laude) in Industrial Engineering from the University of Michigan and an MS degree in Industrial Engineering from Stanford.

EdwardPham
Menashe Elazar PhD Deputy Director ViRx@Stanford for Israel; Dr. Elazar received his Ph.D from the Hebrew University of Jerusalem.

He then joined the laboratory of Professor Jeffrey Glenn's at Stanford School of Medicine as a postdoctoral fellow in 2000 then became a senior research scientist. He initially focused his research on how RNA viruses harness cellular membrane to support their genome’s replication. In recent years, his research expanded to include broad spectrum antivirals targeting host function; viral genome RNA structures as antiviral targets; and other direct-targeting antivirals

EdwardPham
Edward Pham Deputy Director, Translational Research
ViRx@Stanford for Vietnam
View More

Information & Events

Meeting between ViRx@Stanford leadership with the Prime Minister of Vietnam Pham Minh Chinh

Menashe Elazar
Menashe Elazar Deputy Director ViRx@Stanford for Israel View More

Information & Events

Meeting between ViRx@Stanford leadership with the President of Israel Isaac Herzog

Virx@stanford
Information is being updated Information about the person in charge of the country you are choosing will be updated by us in the near future. Please wait for us. Thank you for your interest
Virx@stanford
Information is being updated Information about the person in charge of the country you are choosing will be updated by us in the near future. Please wait for us. Thank you for your interest
Virx@stanford
Information is being updated Information about the person in charge of the country you are choosing will be updated by us in the near future. Please wait for us. Thank you for your interest
Virx@stanford
Information is being updated Information about the person in charge of the country you are choosing will be updated by us in the near future. Please wait for us. Thank you for your interest
Virx@stanford
Information is being updated Information about the person in charge of the country you are choosing will be updated by us in the near future. Please wait for us. Thank you for your interest